FSDDF News and Press, FSD Pharma Inc - Class B From 02/27/19

POINT ROBERTS, Wash. and DELTA, British Columbia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Investorideas.com , a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing interest in renewable energy and sustainable practices within the cannabis...

On February 6, 2019, FSD Pharma ( OTCQB:FSDDF ) announced the termination of its joint venture agreement with Auxly ( otcqx:CBWTF ), a cannabis streaming company. The termination was announced unilaterally by FSD and was included in the same press release that also announced the departure of i...

Earlier this month, Auxly ( CBWTF ) and FSD Pharma ( FSDDF ) announced the termination of a joint-venture agreement between the two parties. As a result, Auxly lost an important future supplier and likely wasted valuable time and resources while FSD will face an upcoming funding shortfall and ...

FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) announced today that its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), a licensed cannabis producer under the Cannabis Act, has received its Standard Pro...

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD”), a licensed producer under the Cannabis Act, today provided a corporate update on operations, strategy and leadership changes. Management Changes On February 6, 2019, the Company announced it had implemen...

FSD Pharma ( OTCQB:FSDDF ) has entered into a supply agreement with Canntab Therapeutics and World Class Extractions Inc. (the “Purchasers”) to purchase hemp flower from Thomas Elcome (the “Supplier”). More news on: FSD Pharma Inc., Healthcare stocks...

FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal Canada NewsWire TORONTO, Feb. 12, 2019 - FSD enters into 3-way supply agreement to purchase up to 1,000 kg of 2018 hemp crop - TORONTO , Feb. 12, 2019 /CNW...

FSD Pharma responds to and corrects misleading Auxly claims Canada NewsWire TORONTO, Feb. 8, 2019 TORONTO , Feb. 8, 2019 /CNW/ - FSD Pharma Inc.(CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9)  a licensed producer under the Cannabis A...

FSD Pharma Inc.(CSE:HUGE) (OTCQB:FSDDF) (FRA:0K9) a licensed producer under the Cannabis Act, responded today to a press release by its former partner, Auxly Cannabis Group Inc. (“Auxly”) to correct misleading claims. FSD Pharma strongly denies th...

Welcome to our Cannabis Earnings series where we break down the latest earnings to help you focus on the most important topics. Introduction We last wrote on Auxly (CBWTF), previously known as Cannabis Wheaton, in April this year. Our conclusion back then was that Auxly was a risky investm...